| 期 |
栏目 |
标题 |
文件 |
| 卷 26, 编号 4 (2019) |
Articles |
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia |
|
| 卷 26, 编号 9 (2019) |
Articles |
Drug-induced nightmares |
|
| 卷 27, 编号 3 (2020) |
Articles |
The benefits of fixed combinations for the treatment of arterial hypertension in women with menopausal disorders: focus on Gipotef |
|
| 卷 27, 编号 5 (2020) |
Articles |
Drug-induced diseases: epidemiology and urgency of the problem |
|
| 卷 27, 编号 6 (2020) |
Articles |
Drug-induced diseases: approaches to diagnosis, correction and prevention. Pharmacovigilance |
|
| 卷 27, 编号 13 (2020) |
Articles |
Drug-induced liver injury with cholestasis. Part 1: focus on drugs for the treatment of cardiovascular diseases and hypoglycemic drugs |
|
| 卷 27, 编号 14 (2020) |
Articles |
Drug-induced liver injury with cholestasis. Part 2: focus on antidiabetic drugs |
|
| 卷 28, 编号 3 (2021) |
Articles |
The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine |
|
| 卷 28, 编号 5 (2021) |
Articles |
Tobacco smoking as a risk factor for the development of drug-induced diseases |
|
| 卷 28, 编号 11 (2021) |
Articles |
Risk factors of drug-induced diseases. Part 1. Classification, non-modified risk factors |
|
| 卷 28, 编号 11 (2021) |
Articles |
Medication errors as risk factor for drug-induced diseases |
|
| 卷 28, 编号 12 (2021) |
Articles |
Risk factors of drug-induced diseases. Part 2. Comorbid diseases and lifestyle factors |
|
| 卷 28, 编号 13 (2021) |
Articles |
Drug-alcohol interactions: focus on central-acting drugs and analgesics |
|
| 卷 28, 编号 13 (2021) |
Articles |
Interactions between alcohol and drugs: focus on drugs used to treat diseases of the cardiovascular system, gastrointestinal tract, antimicrobial drugs |
|
| 卷 29, 编号 1 (2022) |
Articles |
Risk factors of drug-induced diseases. Part 3. Drug-drug and drug-food interactions |
|
| 卷 29, 编号 3 (2022) |
Articles |
Risk factors of drug-induced diseases. Part 4. Medication errors and patient adherence |
|
